Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flaherty

Showing results (21-30 of 714) with videos related to

Pageof 72
Sort By:
Pigment Cell & Melanoma Research|February 14, 2015
Effectively targeting CRAF: rational serendipity targeting SRC?Keith T Flaherty
Pigment Cell & Melanoma Research|September 28, 2023
A twenty year perspective on melanoma therapyKeith T Flaherty
The American Journal of Medicine|June 27, 1983
Comparison of intravenous nitroglycerin and sodium nitroprusside in acute myocardial infarctionJ T Flaherty
Annals of Internal Medicine|November 3, 2010
Narrative review: BRAF opens the door for therapeutic advances in melanomaKeith T Flaherty
Pigment Cell & Melanoma Research|January 15, 2011
Taking stock of translational research in melanoma at the 2010 Society for Melanoma Research CongressKeith T Flaherty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Is it good or bad to find a BRAF mutation?Keith T Flaherty
Cardiology|January 1, 1989
Role of nitroglycerin in acute myocardial infarctionJ T Flaherty
Journal of Travel Medicine|September 12, 2018
One size does not fit all: towards personalized risk assessment in travel medicineGerard T Flaherty
Current Opinion in Oncology|April 13, 2004
New molecular targets in melanomaKeith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Sorafenib in renal cell carcinomaKeith T Flaherty
Pageof 72

Showing results (21-30 of 714) with videos related to

Sort By:
Pageof 72
Pigment Cell & Melanoma Research|February 14, 2015
Effectively targeting CRAF: rational serendipity targeting SRC?Keith T Flaherty
Pigment Cell & Melanoma Research|September 28, 2023
A twenty year perspective on melanoma therapyKeith T Flaherty
The American Journal of Medicine|June 27, 1983
Comparison of intravenous nitroglycerin and sodium nitroprusside in acute myocardial infarctionJ T Flaherty
Annals of Internal Medicine|November 3, 2010
Narrative review: BRAF opens the door for therapeutic advances in melanomaKeith T Flaherty
Pigment Cell & Melanoma Research|January 15, 2011
Taking stock of translational research in melanoma at the 2010 Society for Melanoma Research CongressKeith T Flaherty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Is it good or bad to find a BRAF mutation?Keith T Flaherty
Cardiology|January 1, 1989
Role of nitroglycerin in acute myocardial infarctionJ T Flaherty
Journal of Travel Medicine|September 12, 2018
One size does not fit all: towards personalized risk assessment in travel medicineGerard T Flaherty
Current Opinion in Oncology|April 13, 2004
New molecular targets in melanomaKeith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Sorafenib in renal cell carcinomaKeith T Flaherty
Pageof 72